These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 16981802

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Medical Costs and Health Care Utilization Among Self-Insured Members with Carve-In Versus Carve-Out Pharmacy Benefits.
    Smith JJ, Qiu Y, Lam SV, Lockwood CM, Pegus C, Gleason PP.
    J Manag Care Spec Pharm; 2020 Jun; 26(6):766-774. PubMed ID: 32154745
    [Abstract] [Full Text] [Related]

  • 5. Effect of Carving in Pharmacy Benefits on Utilization and Costs.
    Parekh N, Papa S, Drnach A, Spiegel L, Huang Y, Manolis C, Good CB.
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1317-1324. PubMed ID: 32996397
    [Abstract] [Full Text] [Related]

  • 6. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF, Escarce JJ, Solomon MD, Goldman DP.
    JAMA; 2002 Oct 09; 288(14):1733-9. PubMed ID: 12365957
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
    Harris BN, West DS, Johnson J, Hong SH, Stowe CD.
    J Manag Care Pharm; 2004 Oct 09; 10(5):449-55. PubMed ID: 15369428
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Economic evaluation of targeted biologic therapy in metastatic renal cell carcinoma].
    Ondrácková B, Demlová R, Komínek J.
    Klin Onkol; 2010 Oct 09; 23(6):439-45. PubMed ID: 21351422
    [Abstract] [Full Text] [Related]

  • 16. Prescription drug benefits: Rx for cost management--commentary.
    Carlsen MA.
    Benefits Q; 1993 Oct 09; 9(3):81-8. PubMed ID: 10127207
    [No Abstract] [Full Text] [Related]

  • 17. Utilization and cost of sildenafil in a large managed care organization with a quantity limit on sildenafil.
    Cooke CE, Wong W, Lee H.
    J Manag Care Pharm; 2005 Oct 09; 11(8):674-80. PubMed ID: 16194131
    [Abstract] [Full Text] [Related]

  • 18. Clinical pharmacokinetics of tyrosine kinase inhibitors.
    van Erp NP, Gelderblom H, Guchelaar HJ.
    Cancer Treat Rev; 2009 Dec 09; 35(8):692-706. PubMed ID: 19733976
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.